AIA Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIA Investment Management's BMY Position: Q3 2020 in Review
AIA Investment Management increased its Bristol-Myers Squibb (BMY) stake by 30% in Q3 2020, buying an estimated $76K and bringing the position to 5,512 shares worth $332K. The position accounts for 0.08% of the portfolio, ranked #129.
AIA Investment Management first reported a position in BMY in Q3 2019 and has held it in 5 quarters since. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.
- AIA Investment Management held 5,512 shares of Bristol-Myers Squibb worth $332K as of Q3 2020.
- AIA Investment Management bought 1,262 Bristol-Myers Squibb shares in Q3 2020, an estimated $76K.
- Bristol-Myers Squibb made up 0.08% of AIA Investment Management's portfolio in Q3 2020, its #129 holding.
- AIA Investment Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 5 quarters since.
- 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.
Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.